The development and validation of a new coeliac disease quality of life survey (CD‐QOL)
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aliment Pharmacol Ther 31, 666–675 Summary: Background Previous studies on coeliac disease (CD)‐related quality of life (QOL) have been limited by their use of a ‘generic’ rather than coeliac disease‐specific assessment instruments. Aim To develop and psychometrically validate a new coeliac disease‐specific instrument, the CD‐QOL. Methods Through a series of focus groups, we elicited items from patients that related to the specific nature of their disease and its impact on their basic needs. Through expert review, cognitive debriefing with patients and pilot testing, a scale was developed, refined and administered to 387 patients on a gluten‐free diet from both community‐based support groups and a tertiary care referral centre. Finally, a formal validation study was conducted to assess the psychometric properties of the CD‐QOL. Results The final CD‐QOL has 20 items across four clinically relevant subscales (Limitations, Dysphoria, Health Concerns, and Inadequate Treatment). The CD‐QOL has high internal consistency, reliability, and psychometric validation indicates both convergent and discriminate validity. Conclusions The CD‐QOL is a reliable and valid measure of coeliac disease related QOL. As a new disease‐specific instrument, it is likely to be a useful tool for evaluating patients with this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patrick, D. L., Drossman, D. A., Frederick, I. O., Dicesare, J., & Puder, K. L. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018831127942 · Cited by 761
Self-citationFurther validation of the IBS-QOL: a disease-specific quality-of-life questionnaire
Drossman, D. A., Patrick, D. L., Whitehead, W. E., Toner, B. B., Diamant, N. E., Hu, Y., Jia, H., & Bangdiwala, S. I. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01941.x · Cited by 424
Self-citation
Cited by
Lindfors, K., Ciacci, C., Kurppa, K., Lundin, K. E. A., Makharia, G. K., Mearin, M. L., Murray, J. A., Verdu, E. F., & Kaukinen, K. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0054-z · Cited by 399
Wolf, R. L., Lebwohl, B., Lee, A. R., Zybert, P., Reilly, N. R., Cadenhead, J., Amengual, C., & Green, P. H. R. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-4936-4 · Cited by 206
Self-citationUkkola, A., Mäki, M., Kurppa, K., Collin, P., Huhtala, H., Kekkonen, L., & Kaukinen, K. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.10.011 · Cited by 115
Outcome measures in coeliac disease trials: the Tampere recommendations
Ludvigsson, J. F., Ciacci, C., Green, P. H., Kaukinen, K., Korponay-Szabo, I. R., Kurppa, K., Murray, J. A., Lundin, K. E. A., Maki, M. J., Popp, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314853 · Cited by 100
Self-citationHalmos, E. P., Deng, M., Knowles, S. R., Sainsbury, K., Mullan, B., & Tye‐Din, J. A. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14791 · Cited by 81
Metadata
- Authors
- DORN, S. D., HERNANDEZ, L., MINAYA, M. T., MORRIS, C. B., HU, Y., LESERMAN, J., LEWIS, S., LEE, A., BANGDIWALA, S. I., GREEN, P. H. R., & DROSSMAN, D. A.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2010-02-09
- Volume
- 31
- Issue
- 6
- Pages
- 666-675
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2040480374
- Cited by
- 143
- References
- 2
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The development and validation of a new coeliac disease quality of life survey (CD‐QOL). https://app.cochat.ai/papers/10.1111/j.1365-2036.2009.04220.x
- The paper
- DORN, S. D., HERNANDEZ, L., MINAYA, M. T., MORRIS, C. B., HU, Y., LESERMAN, J., LEWIS, S., LEE, A., BANGDIWALA, S. I., GREEN, P. H. R., & DROSSMAN, D. A. (2010). The development and validation of a new coeliac disease quality of life survey (CD‐QOL). Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2009.04220.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.